13F filer · CIK 923093 ↗
Tudor Investment
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$5.06B
+9.2% on the quarter before
Positions
2,300
803 new · 759 sold out
Top 10
9.1%
of the value
Est. gain
+$108.2M
on stocks held all quarter
Est. return
+5.4%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 15% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Horizon Therapeutics Plc - Us~$73.8MNew · 0.0% → 1.5%+648,672 shares
- Ishares Msci Emerging Markets ETF - Us EtpCALL~$56.9MAdded · 0.4% → 1.5%+1,500,000 underlying
- Coupa Software Inc - Us~$42.4MAdded · 0.2% → 1.0%+535,698 shares
- Ishares China Large-Cap ETF - Us EtpCALL~$33.3MNew · 0.0% → 0.7%+1,178,200 underlying
- Cowen Inc - Us~$27.8MAdded · 0.5% → 1.0%+718,589 shares
- Activision Blizzard Inc - UsPUT~$23.0MNew · 0.0% → 0.5%+300,000 underlying
- Svb Financial Group - UsPUT~$22.9MAdded · 0.0% → 0.5%+99,600 underlying
- Poshmark Inc - Us~$18.7MAdded · 0.0% → 0.4%+1,045,431 shares
- M&T Bank Corp - Us~$17.7MNew · 0.0% → 0.3%+121,956 shares
- Metlife Inc - Us~$17.2MAdded · 0.0% → 0.3%+237,169 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bristol-Myers Squibb Co - Us~$143.7MCut · 0.1% → 0.4%−1,997,667 shares
- Alleghany Corp - Us~$93.4MSold out · 2.0% → 0.0%−111,232 shares
- Biohaven Pharmaceutical Holding Co Ltd - Us~$71.8MSold out · 1.5% → 0.0%−475,004 shares
- Twitter Inc - UsPUT~$48.2MSold out · 1.0% → 0.0%−1,100,000 underlying
- Biohaven Pharmaceutical Holding Co Ltd - UsPUT~$45.4MSold out · 1.0% → 0.0%−300,000 underlying
- SPDR S&P 500 ETF Trust - Us Etp~$42.9MSold out · 0.9% → 0.0%−120,096 shares
- Zendesk Inc - Us~$42.3MSold out · 0.9% → 0.0%−555,855 shares
- Twitter Inc - Us~$41.6MSold out · 0.9% → 0.0%−947,787 shares
- Ishares Msci Emerging Markets ETF - Us Etp~$40.1MCut · 1.6% → 0.8%−1,056,959 shares
- Nike Inc - Us Class B~$26.0MCut · 0.4% → 0.0%−222,656 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ishares Msci Emerging Markets ETF - Us EtpCALLETF Option · shares +300% | 1.5% | $75.8M | — | ||||||||
| Horizon Therapeutics Plc - UsEquity · shares New | 1.5% | $73.8M | — | ||||||||
| Coupa Software Inc - UsEquity · shares +452% · price +34.6% | 1.0% | $51.8M | +$2.4M | ||||||||
| Cowen Inc - UsEquity · shares +128% · price −0.1% | 0.98% | $49.5M | −$11,070 | ||||||||
| Evo Payments Inc - UsEquity · shares −0.5% · price +1.6% | 0.95% | $48.2M | +$769,126 | ||||||||
| Liberty Siriusxm Group - CEquity · shares +0.4% · price +3.8% | 0.89% | $45.0M | +$1.6M | ||||||||
| Ishares Msci Emerging Markets ETF - Us EtpExchange-Traded Fund · shares −51% · price +8.7% | 0.75% | $38.0M | +$3.0M | ||||||||
| Ishares China Large-Cap ETF - Us EtpCALLETF Option · shares New | 0.66% | $33.3M | — | ||||||||
| Cme Group Inc - UsEquity · shares +13% · price −5.1% | 0.48% | $24.1M | −$1.1M | ||||||||
| Svb Financial Group - UsPUTEquity Option · shares +9,960% | 0.46% | $23.2M | — | ||||||||
| Eli LillyEquity · shares +211% · price +13.1% | 0.46% | $23.1M | +$862,525 | ||||||||
| Store Capital Corp - Us ReitEquity · shares +69% · price +2.3% | 0.46% | $23.1M | +$311,939 | ||||||||
| Activision Blizzard Inc - UsPUTEquity Option · shares New | 0.45% | $23.0M | — | ||||||||
| Vmware Inc - UsEquity · shares −40% · price +15.3% | 0.45% | $22.5M | +$3.0M | ||||||||
| AirbnbEquity · shares −0.05% · price −18.6% | 0.42% | $21.2M | −$4.8M | ||||||||
| Bristol-Myers Squibb Co - UsEquity · shares −88% · price +3,206.3% | 0.40% | $20.0M | — | ||||||||
| Medtronic Plc - UsEquity · shares +22% · price −3.8% | 0.38% | $19.1M | −$608,232 | ||||||||
| Poshmark Inc - UsEquity · shares +10,030% · price +14.3% | 0.37% | $18.9M | +$23,367 | ||||||||
| Cvs Health Corp - UsEquity · shares +1,871% · price −2.3% | 0.35% | $17.8M | −$21,152 | ||||||||
| M&T Bank Corp - UsEquity · shares New | 0.35% | $17.7M | — | ||||||||
| Marsh & Mclennan Cos Inc - UsEquity · shares −17% · price +10.8% | 0.35% | $17.6M | +$1.7M | ||||||||
| Metlife Inc - UsEquity · shares +5,391% · price +19.2% | 0.35% | $17.5M | +$51,351 | ||||||||
| JabilEquity · shares +280% · price +18.2% | 0.33% | $16.5M | +$667,850 | ||||||||
| Maxar Technologies Inc - UsEquity · shares +67% · price +176.4% | 0.33% | $16.5M | +$6.3M | ||||||||
| Mobileye Global Inc - UsEquity · shares New | 0.31% | $15.9M | — | ||||||||
| Total · 2,300 positions | 100% | $5.06B | +$108.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 1,046 stocks held throughout, up $108.2M (+5.4%).
- Maxar Technologies Inc - Us+$6.3M+176%
- Ishares Msci Emerging Markets ETF - Us Etp+$3.0M+9%
- Vmware Inc - Us+$3.0M+15%
- Radius Global Infrastructure Inc - Us+$2.4M+25%
- Coupa Software Inc - Us+$2.4M+35%
- Atlassian Corp - Us−$2.3M−39%
- Bill.Com Holdings Inc - Us−$2.5M−18%
- SentinelOne−$2.7M−43%
- Airbnb−$4.8M−19%
- DigitalOcean−$5.1M−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $71.91B+33% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $53.87B−0% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $54.03B−7% | SEC ↗ |
| Q3 2025 | Dec 9, 2025 (amended) | $57.98B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $45.92B+53% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $30.10B+15% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $26.28B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.48B+41% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $19.52B+24% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $15.72B+27% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $12.42B+25% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $9.97B+19% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.38B+30% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.46B+28% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.06B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $4.63B+22% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.81B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $4.27B−29% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $5.98B−3% | SEC ↗ |
| Q3 2021 | Nov 17, 2021 (amended) | $6.16B+16% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $5.29B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $4.99B+41% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.54B+54% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $2.30B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.02B+81% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $1.12B−50% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.23B−23% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.91B−17% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.51B+45% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.42B−52% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $5.06B+27% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $3.98B+38% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.87B−7% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $3.09B−22% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $3.94B+0% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $3.92B+19% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $3.28B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $3.25B−16% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $3.88B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $4.27B−10% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $4.72B+21% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $3.91B | SEC ↗ |